Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Pediatric Chronic Rhinosinusitis Treatment Revenue 1.4 Market Analysis by Type 1.4.1 Global Pediatric Chronic Rhinosinusitis Treatment Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Steroids 1.4.3 Antibiotics 1.4.4 Antifungal Therapy 1.4.5 Others 1.5 Market by Application 1.5.1 Global Pediatric Chronic Rhinosinusitis Treatment Market Share by Application: 2020 VS 2026 1.5.2 Hospital Pharmacies 1.5.3 Retail Pharmacies 1.5.4 Online Pharmacies 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Pediatric Chronic Rhinosinusitis Treatment Market Perspective (2015-2026) 2.2 Pediatric Chronic Rhinosinusitis Treatment Growth Trends by Regions 2.2.1 Pediatric Chronic Rhinosinusitis Treatment Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Pediatric Chronic Rhinosinusitis Treatment Historic Market Share by Regions (2015-2020) 2.2.3 Pediatric Chronic Rhinosinusitis Treatment Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Pediatric Chronic Rhinosinusitis Treatment Market Growth Strategy 2.3.6 Primary Interviews with Key Pediatric Chronic Rhinosinusitis Treatment Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Pediatric Chronic Rhinosinusitis Treatment Players by Market Size 3.1.1 Global Top Pediatric Chronic Rhinosinusitis Treatment Players by Revenue (2015-2020) 3.1.2 Global Pediatric Chronic Rhinosinusitis Treatment Revenue Market Share by Players (2015-2020) 3.1.3 Global Pediatric Chronic Rhinosinusitis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Pediatric Chronic Rhinosinusitis Treatment Market Concentration Ratio 3.2.1 Global Pediatric Chronic Rhinosinusitis Treatment Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Pediatric Chronic Rhinosinusitis Treatment Revenue in 2019 3.3 Pediatric Chronic Rhinosinusitis Treatment Key Players Head office and Area Served 3.4 Key Players Pediatric Chronic Rhinosinusitis Treatment Product Solution and Service 3.5 Date of Enter into Pediatric Chronic Rhinosinusitis Treatment Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Pediatric Chronic Rhinosinusitis Treatment Historic Market Size by Type (2015-2020) 4.2 Global Pediatric Chronic Rhinosinusitis Treatment Forecasted Market Size by Type (2021-2026) 5 Pediatric Chronic Rhinosinusitis Treatment Breakdown Data by Application (2015-2026) 5.1 Global Pediatric Chronic Rhinosinusitis Treatment Market Size by Application (2015-2020) 5.2 Global Pediatric Chronic Rhinosinusitis Treatment Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Pediatric Chronic Rhinosinusitis Treatment Market Size (2015-2020) 6.2 Pediatric Chronic Rhinosinusitis Treatment Key Players in North America (2019-2020) 6.3 North America Pediatric Chronic Rhinosinusitis Treatment Market Size by Type (2015-2020) 6.4 North America Pediatric Chronic Rhinosinusitis Treatment Market Size by Application (2015-2020) 7 Europe 7.1 Europe Pediatric Chronic Rhinosinusitis Treatment Market Size (2015-2020) 7.2 Pediatric Chronic Rhinosinusitis Treatment Key Players in Europe (2019-2020) 7.3 Europe Pediatric Chronic Rhinosinusitis Treatment Market Size by Type (2015-2020) 7.4 Europe Pediatric Chronic Rhinosinusitis Treatment Market Size by Application (2015-2020) 8 China 8.1 China Pediatric Chronic Rhinosinusitis Treatment Market Size (2015-2020) 8.2 Pediatric Chronic Rhinosinusitis Treatment Key Players in China (2019-2020) 8.3 China Pediatric Chronic Rhinosinusitis Treatment Market Size by Type (2015-2020) 8.4 China Pediatric Chronic Rhinosinusitis Treatment Market Size by Application (2015-2020) 9 Japan 9.1 Japan Pediatric Chronic Rhinosinusitis Treatment Market Size (2015-2020) 9.2 Pediatric Chronic Rhinosinusitis Treatment Key Players in Japan (2019-2020) 9.3 Japan Pediatric Chronic Rhinosinusitis Treatment Market Size by Type (2015-2020) 9.4 Japan Pediatric Chronic Rhinosinusitis Treatment Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Pediatric Chronic Rhinosinusitis Treatment Market Size (2015-2020) 10.2 Pediatric Chronic Rhinosinusitis Treatment Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Pediatric Chronic Rhinosinusitis Treatment Market Size by Type (2015-2020) 10.4 Southeast Asia Pediatric Chronic Rhinosinusitis Treatment Market Size by Application (2015-2020) 11 India 11.1 India Pediatric Chronic Rhinosinusitis Treatment Market Size (2015-2020) 11.2 Pediatric Chronic Rhinosinusitis Treatment Key Players in India (2019-2020) 11.3 India Pediatric Chronic Rhinosinusitis Treatment Market Size by Type (2015-2020) 11.4 India Pediatric Chronic Rhinosinusitis Treatment Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Pediatric Chronic Rhinosinusitis Treatment Market Size (2015-2020) 12.2 Pediatric Chronic Rhinosinusitis Treatment Key Players in Central & South America (2019-2020) 12.3 Central & South America Pediatric Chronic Rhinosinusitis Treatment Market Size by Type (2015-2020) 12.4 Central & South America Pediatric Chronic Rhinosinusitis Treatment Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Pfizer 13.1.1 Pfizer Company Details 13.1.2 Pfizer Business Overview and Its Total Revenue 13.1.3 Pfizer Pediatric Chronic Rhinosinusitis Treatment Introduction 13.1.4 Pfizer Revenue in Pediatric Chronic Rhinosinusitis Treatment Business (2015-2020)) 13.1.5 Pfizer Recent Development 13.2 Bayer 13.2.1 Bayer Company Details 13.2.2 Bayer Business Overview and Its Total Revenue 13.2.3 Bayer Pediatric Chronic Rhinosinusitis Treatment Introduction 13.2.4 Bayer Revenue in Pediatric Chronic Rhinosinusitis Treatment Business (2015-2020) 13.2.5 Bayer Recent Development 13.3 Novartis 13.3.1 Novartis Company Details 13.3.2 Novartis Business Overview and Its Total Revenue 13.3.3 Novartis Pediatric Chronic Rhinosinusitis Treatment Introduction 13.3.4 Novartis Revenue in Pediatric Chronic Rhinosinusitis Treatment Business (2015-2020) 13.3.5 Novartis Recent Development 13.4 Sanofi 13.4.1 Sanofi Company Details 13.4.2 Sanofi Business Overview and Its Total Revenue 13.4.3 Sanofi Pediatric Chronic Rhinosinusitis Treatment Introduction 13.4.4 Sanofi Revenue in Pediatric Chronic Rhinosinusitis Treatment Business (2015-2020) 13.4.5 Sanofi Recent Development 13.5 AstraZeneca 13.5.1 AstraZeneca Company Details 13.5.2 AstraZeneca Business Overview and Its Total Revenue 13.5.3 AstraZeneca Pediatric Chronic Rhinosinusitis Treatment Introduction 13.5.4 AstraZeneca Revenue in Pediatric Chronic Rhinosinusitis Treatment Business (2015-2020) 13.5.5 AstraZeneca Recent Development 13.6 Teva Pharmaceutical 13.6.1 Teva Pharmaceutical Company Details 13.6.2 Teva Pharmaceutical Business Overview and Its Total Revenue 13.6.3 Teva Pharmaceutical Pediatric Chronic Rhinosinusitis Treatment Introduction 13.6.4 Teva Pharmaceutical Revenue in Pediatric Chronic Rhinosinusitis Treatment Business (2015-2020) 13.6.5 Teva Pharmaceutical Recent Development 13.7 Sumitomo Dainippon Pharma 13.7.1 Sumitomo Dainippon Pharma Company Details 13.7.2 Sumitomo Dainippon Pharma Business Overview and Its Total Revenue 13.7.3 Sumitomo Dainippon Pharma Pediatric Chronic Rhinosinusitis Treatment Introduction 13.7.4 Sumitomo Dainippon Pharma Revenue in Pediatric Chronic Rhinosinusitis Treatment Business (2015-2020) 13.7.5 Sumitomo Dainippon Pharma Recent Development 13.8 Cipla 13.8.1 Cipla Company Details 13.8.2 Cipla Business Overview and Its Total Revenue 13.8.3 Cipla Pediatric Chronic Rhinosinusitis Treatment Introduction 13.8.4 Cipla Revenue in Pediatric Chronic Rhinosinusitis Treatment Business (2015-2020) 13.8.5 Cipla Recent Development 13.9 Lyra Therapeutics 13.9.1 Lyra Therapeutics Company Details 13.9.2 Lyra Therapeutics Business Overview and Its Total Revenue 13.9.3 Lyra Therapeutics Pediatric Chronic Rhinosinusitis Treatment Introduction 13.9.4 Lyra Therapeutics Revenue in Pediatric Chronic Rhinosinusitis Treatment Business (2015-2020) 13.9.5 Lyra Therapeutics Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Pediatric Chronic Rhinosinusitis Treatment Key Market Segments Table 2. Key Players Covered: Ranking by Pediatric Chronic Rhinosinusitis Treatment Revenue Table 3. Ranking of Global Top Pediatric Chronic Rhinosinusitis Treatment Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Pediatric Chronic Rhinosinusitis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Steroids Table 6. Key Players of Antibiotics Table 7. Key Players of Antifungal Therapy Table 8. Key Players of Others Table 9. Global Pediatric Chronic Rhinosinusitis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 10. Global Pediatric Chronic Rhinosinusitis Treatment Market Size by Regions (US$ Million): 2020 VS 2026 Table 11. Global Pediatric Chronic Rhinosinusitis Treatment Market Size by Regions (2015-2020) (US$ Million) Table 12. Global Pediatric Chronic Rhinosinusitis Treatment Market Share by Regions (2015-2020) Table 13. Global Pediatric Chronic Rhinosinusitis Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 14. Global Pediatric Chronic Rhinosinusitis Treatment Market Share by Regions (2021-2026) Table 15. Market Top Trends Table 16. Key Drivers: Impact Analysis Table 17. Key Challenges Table 18. Pediatric Chronic Rhinosinusitis Treatment Market Growth Strategy Table 19. Main Points Interviewed from Key Pediatric Chronic Rhinosinusitis Treatment Players Table 20. Global Pediatric Chronic Rhinosinusitis Treatment Revenue by Players (2015-2020) (Million US$) Table 21. Global Pediatric Chronic Rhinosinusitis Treatment Market Share by Players (2015-2020) Table 22. Global Top Pediatric Chronic Rhinosinusitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatric Chronic Rhinosinusitis Treatment as of 2019) Table 23. Global Pediatric Chronic Rhinosinusitis Treatment by Players Market Concentration Ratio (CR5 and HHI) Table 24. Key Players Headquarters and Area Served Table 25. Key Players Pediatric Chronic Rhinosinusitis Treatment Product Solution and Service Table 26. Date of Enter into Pediatric Chronic Rhinosinusitis Treatment Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Pediatric Chronic Rhinosinusitis Treatment Market Size by Type (2015-2020) (Million US$) Table 29. Global Pediatric Chronic Rhinosinusitis Treatment Market Size Share by Type (2015-2020) Table 30. Global Pediatric Chronic Rhinosinusitis Treatment Revenue Market Share by Type (2021-2026) Table 31. Global Pediatric Chronic Rhinosinusitis Treatment Market Size Share by Application (2015-2020) Table 32. Global Pediatric Chronic Rhinosinusitis Treatment Market Size by Application (2015-2020) (Million US$) Table 33. Global Pediatric Chronic Rhinosinusitis Treatment Market Size Share by Application (2021-2026) Table 34. North America Key Players Pediatric Chronic Rhinosinusitis Treatment Revenue (2019-2020) (Million US$) Table 35. North America Key Players Pediatric Chronic Rhinosinusitis Treatment Market Share (2019-2020) Table 36. North America Pediatric Chronic Rhinosinusitis Treatment Market Size by Type (2015-2020) (Million US$) Table 37. North America Pediatric Chronic Rhinosinusitis Treatment Market Share by Type (2015-2020) Table 38. North America Pediatric Chronic Rhinosinusitis Treatment Market Size by Application (2015-2020) (Million US$) Table 39. North America Pediatric Chronic Rhinosinusitis Treatment Market Share by Application (2015-2020) Table 40. Europe Key Players Pediatric Chronic Rhinosinusitis Treatment Revenue (2019-2020) (Million US$) Table 41. Europe Key Players Pediatric Chronic Rhinosinusitis Treatment Market Share (2019-2020) Table 42. Europe Pediatric Chronic Rhinosinusitis Treatment Market Size by Type (2015-2020) (Million US$) Table 43. Europe Pediatric Chronic Rhinosinusitis Treatment Market Share by Type (2015-2020) Table 44. Europe Pediatric Chronic Rhinosinusitis Treatment Market Size by Application (2015-2020) (Million US$) Table 45. Europe Pediatric Chronic Rhinosinusitis Treatment Market Share by Application (2015-2020) Table 46. China Key Players Pediatric Chronic Rhinosinusitis Treatment Revenue (2019-2020) (Million US$) Table 47. China Key Players Pediatric Chronic Rhinosinusitis Treatment Market Share (2019-2020) Table 48. China Pediatric Chronic Rhinosinusitis Treatment Market Size by Type (2015-2020) (Million US$) Table 49. China Pediatric Chronic Rhinosinusitis Treatment Market Share by Type (2015-2020) Table 50. China Pediatric Chronic Rhinosinusitis Treatment Market Size by Application (2015-2020) (Million US$) Table 51. China Pediatric Chronic Rhinosinusitis Treatment Market Share by Application (2015-2020) Table 52. Japan Key Players Pediatric Chronic Rhinosinusitis Treatment Revenue (2019-2020) (Million US$) Table 53. Japan Key Players Pediatric Chronic Rhinosinusitis Treatment Market Share (2019-2020) Table 54. Japan Pediatric Chronic Rhinosinusitis Treatment Market Size by Type (2015-2020) (Million US$) Table 55. Japan Pediatric Chronic Rhinosinusitis Treatment Market Share by Type (2015-2020) Table 56. Japan Pediatric Chronic Rhinosinusitis Treatment Market Size by Application (2015-2020) (Million US$) Table 57. Japan Pediatric Chronic Rhinosinusitis Treatment Market Share by Application (2015-2020) Table 58. Southeast Asia Key Players Pediatric Chronic Rhinosinusitis Treatment Revenue (2019-2020) (Million US$) Table 59. Southeast Asia Key Players Pediatric Chronic Rhinosinusitis Treatment Market Share (2019-2020) Table 60. Southeast Asia Pediatric Chronic Rhinosinusitis Treatment Market Size by Type (2015-2020) (Million US$) Table 61. Southeast Asia Pediatric Chronic Rhinosinusitis Treatment Market Share by Type (2015-2020) Table 62. Southeast Asia Pediatric Chronic Rhinosinusitis Treatment Market Size by Application (2015-2020) (Million US$) Table 63. Southeast Asia Pediatric Chronic Rhinosinusitis Treatment Market Share by Application (2015-2020) Table 64. India Key Players Pediatric Chronic Rhinosinusitis Treatment Revenue (2019-2020) (Million US$) Table 65. India Key Players Pediatric Chronic Rhinosinusitis Treatment Market Share (2019-2020) Table 66. India Pediatric Chronic Rhinosinusitis Treatment Market Size by Type (2015-2020) (Million US$) Table 67. India Pediatric Chronic Rhinosinusitis Treatment Market Share by Type (2015-2020) Table 68. India Pediatric Chronic Rhinosinusitis Treatment Market Size by Application (2015-2020) (Million US$) Table 69. India Pediatric Chronic Rhinosinusitis Treatment Market Share by Application (2015-2020) Table 70. Central & South America Key Players Pediatric Chronic Rhinosinusitis Treatment Revenue (2019-2020) (Million US$) Table 71. Central & South America Key Players Pediatric Chronic Rhinosinusitis Treatment Market Share (2019-2020) Table 72. Central & South America Pediatric Chronic Rhinosinusitis Treatment Market Size by Type (2015-2020) (Million US$) Table 73. Central & South America Pediatric Chronic Rhinosinusitis Treatment Market Share by Type (2015-2020) Table 74. Central & South America Pediatric Chronic Rhinosinusitis Treatment Market Size by Application (2015-2020) (Million US$) Table 75. Central & South America Pediatric Chronic Rhinosinusitis Treatment Market Share by Application (2015-2020) Table 76. Pfizer Company Details Table 77. Pfizer Business Overview Table 78. Pfizer Product Table 79. Pfizer Revenue in Pediatric Chronic Rhinosinusitis Treatment Business (2015-2020) (Million US$) Table 80. Pfizer Recent Development Table 81. Bayer Company Details Table 82. Bayer Business Overview Table 83. Bayer Product Table 84. Bayer Revenue in Pediatric Chronic Rhinosinusitis Treatment Business (2015-2020) (Million US$) Table 85. Bayer Recent Development Table 86. Novartis Company Details Table 87. Novartis Business Overview Table 88. Novartis Product Table 89. Novartis Revenue in Pediatric Chronic Rhinosinusitis Treatment Business (2015-2020) (Million US$) Table 90. Novartis Recent Development Table 91. Sanofi Company Details Table 92. Sanofi Business Overview Table 93. Sanofi Product Table 94. Sanofi Revenue in Pediatric Chronic Rhinosinusitis Treatment Business (2015-2020) (Million US$) Table 95. Sanofi Recent Development Table 96. AstraZeneca Company Details Table 97. AstraZeneca Business Overview Table 98. AstraZeneca Product Table 99. AstraZeneca Revenue in Pediatric Chronic Rhinosinusitis Treatment Business (2015-2020) (Million US$) Table 100. AstraZeneca Recent Development Table 101. Teva Pharmaceutical Company Details Table 102. Teva Pharmaceutical Business Overview Table 103. Teva Pharmaceutical Product Table 104. Teva Pharmaceutical Revenue in Pediatric Chronic Rhinosinusitis Treatment Business (2015-2020) (Million US$) Table 105. Teva Pharmaceutical Recent Development Table 106. Sumitomo Dainippon Pharma Company Details Table 107. Sumitomo Dainippon Pharma Business Overview Table 108. Sumitomo Dainippon Pharma Product Table 109. Sumitomo Dainippon Pharma Revenue in Pediatric Chronic Rhinosinusitis Treatment Business (2015-2020) (Million US$) Table 110. Sumitomo Dainippon Pharma Recent Development Table 111. Cipla Business Overview Table 112. Cipla Product Table 113. Cipla Company Details Table 114. Cipla Revenue in Pediatric Chronic Rhinosinusitis Treatment Business (2015-2020) (Million US$) Table 115. Cipla Recent Development Table 116. Lyra Therapeutics Company Details Table 117. Lyra Therapeutics Business Overview Table 118. Lyra Therapeutics Product Table 119. Lyra Therapeutics Revenue in Pediatric Chronic Rhinosinusitis Treatment Business (2015-2020) (Million US$) Table 120. Lyra Therapeutics Recent Development Table 121. Research Programs/Design for This Report Table 122. Key Data Information from Secondary Sources Table 123. Key Data Information from Primary Sources List of Figures Figure 1. Global Pediatric Chronic Rhinosinusitis Treatment Market Share by Type: 2020 VS 2026 Figure 2. Steroids Features Figure 3. Antibiotics Features Figure 4. Antifungal Therapy Features Figure 5. Others Features Figure 6. Global Pediatric Chronic Rhinosinusitis Treatment Market Share by Application: 2020 VS 2026 Figure 7. Hospital Pharmacies Case Studies Figure 8. Retail Pharmacies Case Studies Figure 9. Online Pharmacies Case Studies Figure 10. Pediatric Chronic Rhinosinusitis Treatment Report Years Considered Figure 11. Global Pediatric Chronic Rhinosinusitis Treatment Market Size YoY Growth 2015-2026 (US$ Million) Figure 12. Global Pediatric Chronic Rhinosinusitis Treatment Market Share by Regions: 2020 VS 2026 Figure 13. Global Pediatric Chronic Rhinosinusitis Treatment Market Share by Regions (2021-2026) Figure 14. Porter's Five Forces Analysis Figure 15. Global Pediatric Chronic Rhinosinusitis Treatment Market Share by Players in 2019 Figure 16. Global Top Pediatric Chronic Rhinosinusitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatric Chronic Rhinosinusitis Treatment as of 2019 Figure 17. The Top 10 and 5 Players Market Share by Pediatric Chronic Rhinosinusitis Treatment Revenue in 2019 Figure 18. North America Pediatric Chronic Rhinosinusitis Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Europe Pediatric Chronic Rhinosinusitis Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 20. China Pediatric Chronic Rhinosinusitis Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Japan Pediatric Chronic Rhinosinusitis Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Southeast Asia Pediatric Chronic Rhinosinusitis Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 23. India Pediatric Chronic Rhinosinusitis Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Central & South America Pediatric Chronic Rhinosinusitis Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Pfizer Revenue Growth Rate in Pediatric Chronic Rhinosinusitis Treatment Business (2015-2020) Figure 27. Bayer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Bayer Revenue Growth Rate in Pediatric Chronic Rhinosinusitis Treatment Business (2015-2020) Figure 29. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Novartis Revenue Growth Rate in Pediatric Chronic Rhinosinusitis Treatment Business (2015-2020) Figure 31. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Sanofi Revenue Growth Rate in Pediatric Chronic Rhinosinusitis Treatment Business (2015-2020) Figure 33. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. AstraZeneca Revenue Growth Rate in Pediatric Chronic Rhinosinusitis Treatment Business (2015-2020) Figure 35. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Teva Pharmaceutical Revenue Growth Rate in Pediatric Chronic Rhinosinusitis Treatment Business (2015-2020) Figure 37. Sumitomo Dainippon Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Sumitomo Dainippon Pharma Revenue Growth Rate in Pediatric Chronic Rhinosinusitis Treatment Business (2015-2020) Figure 39. Cipla Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. Cipla Revenue Growth Rate in Pediatric Chronic Rhinosinusitis Treatment Business (2015-2020) Figure 41. Lyra Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. Lyra Therapeutics Revenue Growth Rate in Pediatric Chronic Rhinosinusitis Treatment Business (2015-2020) Figure 43. Bottom-up and Top-down Approaches for This Report Figure 44. Data Triangulation Figure 45. Key Executives Interviewed

Pfizer Bayer Novartis Sanofi AstraZeneca Teva Pharmaceutical Sumitomo Dainippon Pharma Cipla Lyra Therapeutics